OS
OS Therapies Incorporated (OSTX)
AMEX·Healthcare·Biotechnology
$1.64
-7.36%
Mkt Cap $74.41M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$0.14 | -$0.36 | -168.38% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.16 | -$0.21 | -31.25% | — | — |
| Q3 2025 Aug 19, 2025 | — | — | — | -$0.15 | -$0.19 | -26.67% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.11 | -$0.18 | -63.64% | — | — |
| Q1 2025 Mar 31, 2025 | — | — | — | -$0.14 | -$0.24 | -71.43% | — | — |
| Q4 2024 Nov 15, 2024 | $300.00K | — | — | -$0.12 | -$0.18 | -50.00% | — | — |
| Q3 2024 Aug 14, 2024 | — | $139.85K | — | -$0.26 | -$0.26 | +0.00% | — | — |
| Q2 2024 May 20, 2024 | — | $132.00K | — | — | -$0.07 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.07 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.09 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.00 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.00 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$0.00 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.00 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.00 | — | — | — |